News summary

May 9baccaratwizardofoz, Xiansheng Pharmaceutical (02096baccaratwizardofoz.HK) spent HK$3.94 million to repurchase 680,000 shares, at a repurchase price per share of between 5baccaratwizardofoz.78 to HK$5.8.

Newsletter text

[Xiansheng Pharmaceutical spent nearly HK$4 million to repurchase more than 680,000 shares] On May 9, Hong Kong-listed company Xiansheng Pharmaceutical (02096.HK) conducted an equity repurchase operation. The company publicly disclosed that it was trading at HK$5.78 -5.8 per sharebaccaratwizardofoz680,000 shares were repurchased at the price of 2010, with a total transaction value of 3.94 million Hong Kong dollars. This repurchase action reflects Xiansheng Pharmaceutical's confidence in its own value and good expectations for future development.